NHS staff boycott Palantir’s data platform over ethical concerns - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
商业快报

NHS staff boycott Palantir’s data platform over ethical concerns

Controversial US tech group was awarded a £330mn contract in 2023 to collate hospital and patient information
00:00

{"text":[[{"start":9.59,"text":"A growing number of NHS staff are refusing to work on Palantir’s health data platform over ethical concerns about the controversial US tech company."}],[{"start":21.68,"text":"The technology company was awarded a £330mn contract in 2023 to create the Federated Data Platform (FDP), which collates NHS operational data such as waiting lists, staffing, patient information and operating theatre schedules."}],[{"start":41.01,"text":"Palantir’s NHS role has become increasingly contentious owing to its work in the US defence sector and co-founder and chief executive Alex Karp’s outspoken backing for Donald Trump’s immigration crackdown. "}],[{"start":56.239999999999995,"text":"“People are saying, ‘I refuse to work on this software. You have to find something else for me to do’,” said one senior NHS official who manages data analysts. “They’re calling it a workplace adjustment. It would be like, you know, if you were disabled and needed a different desk, they’re literally treating it like that.” "}],[{"start":77.78999999999999,"text":"They added: “It’s a significant number of people but there is also a silent majority that feel uncomfortable but wouldn’t want to put their head above a parapet.”"}],[{"start":87.69,"text":"Another senior health official, who has worked in analytics for the NHS for almost two decades, said they would not use the FDP as it was run by an “ethically bankrupt” organisation. "}],[{"start":101.22,"text":"“I will continue to refuse to engage with any work involving this company,” they said. “I know that there are staff who are already working as slowly as they can when pressured to work with Palantir.”"}],[{"start":116.66,"text":"One health data official said their team was “not interested in using [the FDP] as it doesn’t do anything new for us” and “their method is to just not use it”."}],[{"start":128.91,"text":"“It’s a mix of not needing to because other methods are better, and ethics. It makes me feel sick every time I log into the thing and I know I’m not alone in that. Colleagues are avoiding the news because it makes them feel terrible.” "}],[{"start":144.9,"text":"A more junior member of NHS staff said: “Last year, I contacted my team lead to officially refuse to work with the FDP and I was told that I would be found projects outside of the FDP wherever possible.”"}],[{"start":160.73000000000002,"text":"A total of 123 hospital trusts out of 205 in England are using the FDP, according to the latest NHS data, with 80 “reporting benefits” at the end of February. Meanwhile, another 45 hospital trusts have “signed up” to the platform. "}],[{"start":180.17000000000002,"text":"According to the Treasury’s National Infrastructure and Service Transformation Authority, the FDP project has the highest available “green rating” for successful delivery on time and on budget."}],[{"start":194.07000000000002,"text":"MPs, NHS staff and medical trade unions have also voiced concerns about Palantir’s suitability for managing data in national health systems."}],[{"start":205.8,"text":"The FT reported earlier this week that UK ministers have sought advice on triggering a break clause in Palantir’s contract as they come under mounting pressure to eject the company from NHS England data systems. "}],[{"start":219.93,"text":"Palantir’s UK chief Louis Mosley told The Times this week: “Having a review clause in a contract is good and normal practice. However, what some ideologically motivated campaigners are suggesting should happen would harm patient care and prevent some of the biggest challenges facing the NHS from being tackled.” "}],[{"start":240.33,"text":"A briefing from officials for health secretary Wes Streeting ahead of a meeting with Mosley in June 2025, obtained through a Freedom of Information request by the digital rights organisation Foxglove, noted: “The public perception of the FDP during the procurement, and then in delivery, has been affected by the profile of Palantir. "}],[{"start":264.41,"text":"“We do not know the extent to which this is impacting on delivery. It is, however, likely to make it harder to go further with the FDP, and to encourage the inclusion of GP data locally.” "}],[{"start":278.44,"text":"The briefing added: “It may be useful to consider ways in which we can mitigate this.”"}],[{"start":284.87,"text":"During an appearance on the Guardian Politics Weekly podcast last week, Streeting was asked if he could understand why there were concerns about the ethics of the Palantir contract, to which he replied: “Yes, for a few reasons.” "}],[{"start":301.56,"text":"“Firstly, when you look at some of the things that Palantir’s leaders have said in the States, when you look at their political views and their outlook.”"}],[{"start":311.25,"text":"When asked about co-founder Peter Thiel’s support for Trump, Streeting said: “If you were to put him and some of those Palantir bosses on the political spectrum in the UK, they would be well off to the right of even Kemi Badenoch’s Conservative Party, which is saying something at the moment. And so there’s a question people have about values.”"}],[{"start":332.98,"text":"An NHS spokesperson said: “All suppliers, including Palantir, and their staff operate only under NHS instruction, with all data access remaining under NHS control and governed by strict contractual confidentiality obligations.”"}],[{"start":352.52000000000004,"text":"A Palantir spokesperson said: “We are happy to discuss any concerns from NHS staff, and there is a lot of false information circulating about the company and how our software works. "}],[{"start":368.06000000000006,"text":"“It is also important to understand that the evidence of the past two years of delivery is that our software is helping improve patient care.”"}],[{"start":null,"text":""}],[{"start":388.80000000000007,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1775179375_7287.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

新型“地平线摩天楼”能否重振香港活力?

面对深圳低价优势带来的竞争,香港这座城市正寄望于新的Central Yards项目,重振购物和休闲业。

特朗普邀请白大拿出任新的白宫新闻秘书

美国总统暗示,在其所属政党中期选举惨败后将采取强硬策略。

法国极左翼总统候选人承诺对社会进行“革命性”改造

大规模抗议为梅朗雄助势之际,让-吕克•梅朗雄以一场两万人集会展现实力。

伯克希尔•哈撒韦加大股票回购力度,回购金额达96亿美元

保险业务增长放缓拖累业绩,季度营业利润同比下降5.8%。

印尼总统顾问称明晟的降级威胁“做得太过了”

这位印尼总统普拉博沃•苏比延多的兄弟兼商业巨头称,若印尼被剔出全球指数,将造成“严重后果”。

震动土耳其的200亿美元欺诈丑闻

投资者损失数十亿美元。批评人士谴责埃尔多安政府任人唯亲。
设置字号×
最小
较小
默认
较大
最大
分享×